{"name":"Cosette Pharmaceuticals, Inc.","slug":"cosette-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNMmVUVWFPY0hRNm5lVE9IbVRrUEwyQVFQeUgtZFlMWUtpajRCaFBjSV92VjNFVWhMYUV0eDhnT2RvVjluZFFMVVA3VU1qdkRmYkhFRFh2LXRFWUlNNFhWV2NEY2p4VGxMN3gyNkxESDdHb3ZwMEhsSU5zU2d0NjZKNUxPYUZ2LUJkdzJ1Y0dEZjRKWkRWVWJ5UmdiUmw3N0xUSGk1MWswdHozeEkwdWNlYzAzcHFqbW9JcXVkRVQwNDV3LWRnQm9nYjJ6UWZsSmh6ZEhWZmhsV1pHZ1hsaVB2M2NFTWZ0Yi1xcXZ2aFZaaVZLM3hMeWJfU2VPWVV0SUppZ3RIU3hVQQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Business Wire","summary":"Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN - Business Wire","headline":"Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWVhyQjRYQ0RyWkFfaUZ1UkpqdFBlTWZsWWVXeFdZOXhmMHRzNHVCQ2N1TEFkSWFwVzExMEVNcGRaUkFMOTNzTm5uU0tITS1BSV9nektOVkR6MHdEYno1bU1JYW1TQXoyVzdMM1lLRzNSZUg5clFvc2QwWGFaRnZiRHUtODM3clNBY1hSdV9qOGRCQXZfMUpGa3U0TQ?oc=5","date":"2025-12-16","type":"regulatory","source":"Yahoo Finance","summary":"Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therap","headline":"Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl ","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-12-16","type":"regulatory","source":"Business Wire","summary":"Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therap","headline":"Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBSZUE0bHNncFJzVmZPYy11WkNudkt1ZS1JMVgxY0Fsa25PRWs2N3JGcElabC1XRVd5TDhSNGxQZTlCS2ROTWVNY1drZkw4dGlyR1B0QXVfQWJCREpYSmFHekR5LVFyeVpqLUpKcW9LajFuLTBDUzBVaHpWMA?oc=5","date":"2025-12-15","type":"deal","source":"NJBIZ","summary":"Cosette, Mayne Pharma terminate $430M acquisition deal - NJBIZ","headline":"Cosette, Mayne Pharma terminate $430M acquisition deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOTy1nbVNLU3pyb1NXVG9EcTVIQ2xkMEZkZXNJQlVxcDd5WkVSNHVlYUp1dWFmdVFLUEdlM3lIc1FPZEVPLXhmUUNuNEtPMHFaUnlYWUVYVkh1QTVVS3V0YmxwTTM1SGFKekZtOFl5U2JLVENUYzhEWnJpbW9vSTVHM2wzZnVnaER0SW9SU3YwRGtLcGp5YVFZbWQxcDlESzFxc291d2NNelQwWnRzU19FYw?oc=5","date":"2025-12-12","type":"pipeline","source":"ROI-NJ","summary":"Cosette Pharmaceuticals’ acquisition of Mayne Pharma is terminated - ROI-NJ","headline":"Cosette Pharmaceuticals’ acquisition of Mayne Pharma is terminated - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPRk1INlV2amtyZjZzeDhTT3lWODVsNkJHQmU4UnlWbzRETDBWMnNHVHBuMUhVVy04U1gteHJxVTlIbWZqdUd5SmctRGZGajBCQUp0X3V2b2pKRXd6LXhKN2ZxZklxdXJ1elFQa2ZxWmp1RWZzUHQ5SzNxMGhzaHJhd1dGeGVPX25jZlJrbVJYN1FKOWlxcE9VQ3JXVGFCRHVfSlByRmhrT1I0MGhTTUhjOXVTLW5WX0ttV3FZRnlEWC1famk4dHRkeDRWZVc3ZFUyUmxtdVFXZEgzLVlnZnQwanpKRGVpMUdjRmNEVzRXMWNVQQ?oc=5","date":"2025-12-12","type":"pipeline","source":"Capital Brief","summary":"Mayne Pharma's Cosette takeover saga could return to court as break fee dispute erupts - Capital Brief","headline":"Mayne Pharma's Cosette takeover saga could return to court as break fee dispute erupts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPcUYxVmJxX3RudVVGNkxvdm1JOHJRTWFQWGJtMzJqcmZPSnlOSWVGZTFhVlVHNHNNdUZPWG5FY2J6dVhWOFVYVFkxQW1iUkFKY3l2UmctUk53anFsUjJ1VUd4WVY4UUNkTXJxd1RQZFZhYUE0ZnJray1xcXJBTUg1SzVOemxoanEtVllsMVM0aGNFOGZaNlk1Q0E2ZWZrSXZIbHktM0I4V3ZyMnEt?oc=5","date":"2025-12-11","type":"pipeline","source":"Business Wire","summary":"Termination of Proposed Acquisition of Mayne Pharma - Business Wire","headline":"Termination of Proposed Acquisition of Mayne Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQZ0pDMGtVQXhvakxVa29ZRFd3bm1YZFd1am9rTTZtdld1eDN3M2ZtQ1VsUGVvemc2aEI5MVlfWTlMOHl0TjdZS3ByOEw2VHhZdEZwQjZ3Vml6dk1MZG44N0FLVHFrRVZ5TTVIQzBkNVlmZFF6aGg1ekhLR25RYVlTOXl2ZVZUSWpSRFA4b0N4S1VjRXM?oc=5","date":"2025-11-21","type":"pipeline","source":"Sharecafe","summary":"Mayne Pharma Halted Amid Cosette Acquisition Bid - Sharecafe","headline":"Mayne Pharma Halted Amid Cosette Acquisition Bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNODI3QXp3UDFDcG9PNnZtd3NUazFGdEZyNVd3MEpfNy1CZkxXeE1zV0xpQ3JVd2xLYlJzcjVUQlJsaWlvT0pVVk9fcllDS3FyNVVMSDU3Qmd0ckdaQTNrRlNoUjYtUUJlckV4RHp2Z3VOTzlvNlBVbVNaVkluYjFfNW82NXlFUHMtcnRTWmEyTjFCU1ZrUzBNbUdjUlFxNV9uWmdXOWkzU3BRQkdnUWlNeE4tZFVFRDY5NGc?oc=5","date":"2025-11-20","type":"pipeline","source":"WSJ","summary":"Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma - WSJ","headline":"Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNY25mNzk0Q3ppN0NVenY5dTl2bDRXNlg2NTFBbXRUaFg0R2JWX05aXzEtWVlHSGl0YW1SNG9vbnpZVGRqYkxXX1NrUUNxbk12Q0RNX3hPeHlVRnJTcjg0UVRKbjVoU1pIQWRxNkdQLVFtTGFmWE9jNnpHdFNQbnowSS1BSmtYZ2VyNGpONnZma0lsUjlsZEc3WjhENnlqY2stSE54NmpjUzZwVlZ6bWZCdHFtRExzMGZMRk5tblFhdmhENGVCR09aT1Fra2tEQQ?oc=5","date":"2025-07-01","type":"regulatory","source":"BioSpace","summary":"Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs - BioSpace","headline":"Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQZHNicmE4RUxkRFgzQXFxaTM2a1hwWWFZSm5KZlBNd3RpRk51MXdadm1lQXFwVXFpMnpGVnBKdVlObXQ2RnRVRFpVYkoyVFZHUWc0bjU2TTdWcXV6S2tYdkQyWXFoeFhyOE9oYktUMEZWYlROb0gzQ0ZYNnp6X3Y5cXRNYzRBUF9jdkFSMUtjUHN4UGc2T3RnQWR2ei1sNmVNZi1USjdVa1cyY2NmaG1oNG5LdjU3T2dnS2tiVy1zZ0h4T2NkZVpHR2ZB?oc=5","date":"2025-06-04","type":"deal","source":"AFR","summary":"MYX ASX: Cosette terminates $672m Mayne Pharma deal as legal challenge looms - AFR","headline":"MYX ASX: Cosette terminates $672m Mayne Pharma deal as legal challenge looms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQbEdOQk1jMVFsckFoYzdqQXM4TXBIVkFoaGZ1RjlsZ2xRMm1JcnJyTmE0cFlPc1U5bFU5STNHOVFlZ3N1WDNTZ2YzYTNNN3Z3MEFNY3o5VllabDh2R0NJa2tVNWM5dE1QaDlUdlZLZ1E1Qk82TDZxS2oyZ0l4bTNmaHBTVFVUWGZ6NW1MUkFOSEZvM2ViRC1jRGUzSEo1U3hGNTYyOGg1dTJIcmpLRW10U1c3TERfSWlQdEhYa2pRQWxqLWJoT3VKeEdnbElrbGtI?oc=5","date":"2025-05-21","type":"deal","source":"Reuters","summary":"Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal - Reuters","headline":"Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}